← FDA Drug Approvals (Drugs@FDA)
MICAFUNGIN
NDA · New Drug Application · Sponsor: TEVA PHARMS USA INC · Approved 2021-07-30
Drug application
- FDA Application #
NDA212125- Application type
- New Drug Application
- Brand name
- MICAFUNGIN
- Generic name
- Micafungin Sodium
- Active ingredients
- MICAFUNGIN SODIUM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2021-07-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown